Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 78.00 | 100.00 | 0.7800 | 0.7440 | |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 81.00 | 100.00 | 0.8100 | 0.7807 | |
| BT-20 | Erlotinib | 0.01 | uM | 8 | 156.25 | 28.44 | 107.00 | 100.00 | 1.0700 | 1.0760 |
| BT-20 | 17-AAG | 0.000302 | uM | 8 | 156.25 | 28.44 | 87.00 | 100.00 | 0.8700 | 0.8522 |
| BT-20 | Erlotinib | 0.31623 | uM | 8 | 156.25 | 28.44 | 160.00 | 100.00 | 1.6000 | 1.5915 |
| BT-20 | Erlotinib | 1 | uM | 8 | 156.25 | 28.44 | 130.00 | 100.00 | 1.3000 | 1.3112 |
| BT-20 | Lapatinib | 10 | uM | 8 | 156.25 | 28.44 | 53.00 | 100.00 | 0.5300 | 0.4094 |
| BT-20 | Linsitinib | 0.031623 | uM | 8 | 156.25 | 28.44 | 135.00 | 100.00 | 1.3500 | 1.3598 |
| BT-20 | 17-AAG | 0.0001 | uM | 8 | 156.25 | 28.44 | 127.00 | 100.00 | 1.2700 | 1.2817 |
| BT-20 | Erlotinib | 0.031623 | uM | 8 | 156.25 | 28.44 | 167.00 | 100.00 | 1.6700 | 1.6534 |
| BT-20 | Lapatinib | 1 | uM | 8 | 156.25 | 28.44 | 150.00 | 100.00 | 1.5000 | 1.5009 |
| BT-20 | Linsitinib | 10 | uM | 8 | 156.25 | 28.44 | 171.00 | 100.00 | 1.7100 | 1.6882 |
| BT-20 | Erlotinib | 3.1623 | uM | 8 | 156.25 | 28.44 | 161.00 | 100.00 | 1.6100 | 1.6004 |
| BT-20 | Erlotinib | 10 | uM | 8 | 156.25 | 28.44 | 189.00 | 100.00 | 1.8900 | 1.8407 |
| BT-20 | Linsitinib | 0.31623 | uM | 8 | 156.25 | 28.44 | 173.00 | 100.00 | 1.7300 | 1.7055 |
| BT-20 | Linsitinib | 0.0033113 | uM | 8 | 156.25 | 28.44 | 127.00 | 100.00 | 1.2700 | 1.2817 |
| BT-20 | 17-AAG | 0.01 | uM | 8 | 156.25 | 28.44 | 42.00 | 100.00 | 0.4200 | 0.2398 |
| BT-20 | Lapatinib | 3.1623 | uM | 8 | 156.25 | 28.44 | 83.00 | 100.00 | 0.8300 | 0.8048 |
| BT-20 | 17-AAG | 0.001 | uM | 8 | 156.25 | 28.44 | 122.00 | 100.00 | 1.2200 | 1.2317 |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 76.00 | 100.00 | 0.7600 | 0.7192 | |
| BT-20 | 17-AAG | 0.0031623 | uM | 8 | 156.25 | 28.44 | 85.00 | 100.00 | 0.8500 | 0.8286 |
| BT-20 | Linsitinib | 1 | uM | 8 | 156.25 | 28.44 | 65.00 | 100.00 | 0.6500 | 0.5773 |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 92.00 | 100.00 | 0.9200 | 0.9102 | |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 56.00 | 100.00 | 0.5600 | 0.4529 | |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 46.00 | 100.00 | 0.4600 | 0.3036 |